Integral Diagnostics Stock Price, News & Analysis (ASX:IDX)

A$3.28
+0.03 (+0.92 %)
(As of 09/23/2019 05:34 AM ET)
Today's Range
A$3.26
Now: A$3.28
A$3.29
50-Day Range
A$3.00
MA: A$3.24
A$3.45
52-Week Range
A$2.32
Now: A$3.28
A$3.44
Volume365,915 shs
Average VolumeN/A
Market Capitalization$568.60 million
P/E Ratio24.66
Dividend Yield3.10%
BetaN/A
Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia. The company provides its services through a network of 53 sites under the Lake Imaging, South Coast Radiology, and Global Diagnostics brands in Victoria, Queensland, and Western Australia, as well as through specialist Radiology Group, and Trinity MRI and Cavendish Radiology in Auckland, New Zealand. Integral Diagnostics Limited is headquartered in North Melbourne, Australia.

Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 3 5339 0704

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$232.39 million
Cash FlowA$0.13 per share
Book ValueA$0.81 per share

Profitability

Miscellaneous

Employees928
Market Cap$568.60 million
Next Earnings DateN/A
OptionableNot Optionable

Receive IDX News and Ratings via Email

Sign-up to receive the latest news and ratings for IDX and its competitors with MarketBeat's FREE daily newsletter.


Integral Diagnostics (ASX:IDX) Frequently Asked Questions

What is Integral Diagnostics' stock symbol?

Integral Diagnostics trades on the ASX under the ticker symbol "IDX."

How often does Integral Diagnostics pay dividends? What is the dividend yield for Integral Diagnostics?

Integral Diagnostics declared a Interim dividend on Saturday, February 23rd. Shareholders of record on Tuesday, April 2nd will be paid a dividend of 0.05 per share on Tuesday, April 2nd. This represents a dividend yield of 1.85%. The ex-dividend date of this dividend is Friday, March 1st. View Integral Diagnostics' Dividend History.

Has Integral Diagnostics been receiving favorable news coverage?

Media coverage about IDX stock has been trending somewhat negative on Monday, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Integral Diagnostics earned a coverage optimism score of -1.3 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Integral Diagnostics.

Who are some of Integral Diagnostics' key competitors?

Who are Integral Diagnostics' key executives?

Integral Diagnostics' management team includes the folowing people:
  • Dr. Ian Kadish, CEO, MD & Director (Age 56)
  • Ms. Anne Lockwood, Chief Financial Officer
  • Dr. Chien Ping Ho, Exec. Director
  • Dr. Sally Sojan, Exec. Director
  • Mrs. Kathryn Davies BBus, GAICD, CPA, Company Sec.

What is Integral Diagnostics' stock price today?

One share of IDX stock can currently be purchased for approximately A$3.28.

How big of a company is Integral Diagnostics?

Integral Diagnostics has a market capitalization of $568.60 million and generates $232.39 million in revenue each year. Integral Diagnostics employs 928 workers across the globe.View Additional Information About Integral Diagnostics.

What is Integral Diagnostics' official website?

The official website for Integral Diagnostics is http://www.integraldiagnostics.com.au/.

How can I contact Integral Diagnostics?

The company can be reached via phone at 61 3 5339 0704.


MarketBeat Community Rating for Integral Diagnostics (ASX IDX)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  7 (Vote Outperform)
Underperform Votes:  7 (Vote Underperform)
Total Votes:  14
MarketBeat's community ratings are surveys of what our community members think about Integral Diagnostics and other stocks. Vote "Outperform" if you believe IDX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IDX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/23/2019 by MarketBeat.com Staff

Featured Article: Economic Bubble

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel